The market for neurological products is currently on the rise in India. Due to stress, changes in lifestyle and increased aging, neurological disorders are on the rise. For this reason, the pharma sector has now turned its attention to neuro care. The various Indian neuro pharmaceutical companies have started focusing on the advanced technology and global quality approach.
The key strategies are expected to help them to provide for the increasing demand locally as well as internationally. Here, we present the advantages, recent developments, and showcase a key member of this category. Whether you are a healthcare provider or a pharma distributor, this guide will assist you to be updated.
The list of Indian companies manufacturing neuro medicine is very big. Some of them are as follows:
Taksa Pharmaceuticals Private Limited
Lifecare Neuro Products Limited
Lifevision Healthcare
NeuroVends
Neuracle Lifesciences
Fawn Incorporation
Lifecare Psychiatry Care
Psycogen Captab
Pax Healthcare
Krishalr Pharmaceuticals
Benefits of Choosing Indian Companies Manufacturing Neuro Medicine
To begin with, the Indian neuro medicine companies have certain inherent strengths that can be of great assistance in neurology.
First of all, the country boasts of a large pool of well trained human resource in the pharmaceutical industry.
Next, the neuro medicine manufacturing companies have the latest technology compared to the technologies of the previous years. That is why enterprises make medicines that are of fine quality at the international level.
Thirdly, the affordable costs of neuro medicines to be within most pocket reaches compared to some of the specialized hospitals.
Click Here to Get Best Manufacturing Quote
Moreover, it is also pertinent to note that most of the Indian companies manufacturing neuro medicine have certification in WHO/GMP/ISO. This aids in the provision of safety, quality and reliability.
Furthermore, there are numerous firms in support of the pcd pharma franchise business models. That is, the distributor and the entrepreneur gain access to such promo material, marketing assistance, and exclusive licensing.
In addition, the Indian neuro pharma companies are diversifying their portfolio. These companies are making efforts to provide medicine for antidepressant, anti-anxiety, bipolar disorder, schizophrenia, neuropathic pain, epilepsy, & neurological disorder.
Current Trends in the Indian Neuro Pharma Sector
Neuro pharma also has equally experienced steady growth in the region particularly in India. A research conducted by Research and Markets revealed that India neuro medicine market will grow at 8.7% of CAGR in the forecast period between 2023 and 2030, and will reach USD 5.5 billion. There are enhanced awareness, the increase in prevalence of mental diseases, and enhanced healthcare sector.
Some of the Indian companies manufacturing neuro medicine now combine several medicines in a single dosage for effective results. Furthermore, there is increasing need for extended-release tablets and liquid products.
Taksa Pharma: A Reliable Partner in Neuro Medicine Manufacturing in India
Taksa Pharma is making its niche in the Indian neuro pharmaceutical companies list since 2017. Founded in India (Dera Bassi, Punjab), the company operates in neuropsychiatric medicine field to manufacture and market. The current drugs that they offer are antipsychotics, neuropathic pain, antidepressants, bipolar disorder, anxiolytics, schizophrenia, and anti-epileptics. They deal as a trusted manufacturer, supplier, distributor, and exporter of neuropsychiatric medicines in India and globally.
We can say that what differentiate Taksa Pharma from the others are the good infrastructure and the high ethical standards. Their respective manufacturing units are WHO-GMP & ISO 9001-2015 certified, compliance with high standards of hygiene practices.
Most importantly, Taksa Pharma complies with the key value: the establishment of long term cooperation with partners and clients. For these reasons, it is becoming easier for Indian customers to opt for them as their preferred choice.
Final Words
At last, it can be stated that Indian neurology pharma companies are set to redefine the future of mental health. These are what they can be described to represent all at once innovation, affordability and reliability. Thus, the neuro segment holds scope for constant growth with demand coupled with awareness that has been on the rise.
The market leader such as Taksa Pharmaceuticals is thus setting high standards on the quality and customers’ satisfaction. No matter whether you are a distributor, a hospital or a wholesaler, this is an appropriate time for you to partner with a reputable company. The future of neuro segment medicines manufacturing and supplying in India seems quite stable. Finally, there are lots of opportunities for all those who want to be a part of this segment.
